185 related articles for article (PubMed ID: 16179374)
21. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
22. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
Juliusson G; Oscier DG; Fitchett M; Ross FM; Stockdill G; Mackie MJ; Parker AC; Castoldi GL; Guneo A; Knuutila S; Elonen E; Gahrton G
N Engl J Med; 1990 Sep; 323(11):720-4. PubMed ID: 2201915
[TBL] [Abstract][Full Text] [Related]
23. The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia.
Karakosta M; Manola KN
Hematology; 2016 Oct; 21(9):526-35. PubMed ID: 27077766
[TBL] [Abstract][Full Text] [Related]
24. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
25. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
26. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.
Baliakas P; Iskas M; Gardiner A; Davis Z; Plevova K; Nguyen-Khac F; Malcikova J; Anagnostopoulos A; Glide S; Mould S; Stepanovska K; Brejcha M; Belessi C; Davi F; Pospisilova S; Athanasiadou A; Stamatopoulos K; Oscier D
Am J Hematol; 2014 Mar; 89(3):249-55. PubMed ID: 24166834
[TBL] [Abstract][Full Text] [Related]
28. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Ito M; Iida S; Inagaki H; Tsuboi K; Komatsu H; Yamaguchi M; Nakamura N; Suzuki R; Seto M; Nakamura S; Morishima Y; Ueda R
Jpn J Cancer Res; 2002 Jun; 93(6):685-94. PubMed ID: 12079517
[TBL] [Abstract][Full Text] [Related]
29. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
[TBL] [Abstract][Full Text] [Related]
31. CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.
Buhmann R; Kurzeder C; Rehklau J; Westhaus D; Bursch S; Hiddemann W; Haferlach T; Hallek M; Schoch C
Br J Haematol; 2002 Sep; 118(4):968-75. PubMed ID: 12199774
[TBL] [Abstract][Full Text] [Related]
32. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract][Full Text] [Related]
33. Culture and Harvest of CpG-Stimulated Peripheral Blood or Bone Marrow in Chronic Lymphocytic Leukemia.
Miller CR; Heerema NA
Methods Mol Biol; 2019; 1881():27-34. PubMed ID: 30350195
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
35. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
Ferrajoli A; Keating MJ; Manshouri T; Giles FJ; Dey A; Estrov Z; Koller CA; Kurzrock R; Thomas DA; Faderl S; Lerner S; O'Brien S; Albitar M
Blood; 2002 Aug; 100(4):1215-9. PubMed ID: 12149200
[TBL] [Abstract][Full Text] [Related]
36. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance.
Koski T; Karhu R; Visakorpi T; Vilpo L; Knuutila S; Vilpo J
Eur J Haematol; 2000 Jul; 65(1):32-9. PubMed ID: 10914937
[TBL] [Abstract][Full Text] [Related]
37. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
38. Examination of clonal evolution in chronic lymphocytic leukemia.
Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
[TBL] [Abstract][Full Text] [Related]
39. Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.
Méhes G
Pathol Oncol Res; 2005; 11(4):205-10. PubMed ID: 16388316
[TBL] [Abstract][Full Text] [Related]
40. A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemia.
López C; Baumann T; Costa D; López-Guerra M; Navarro A; Gómez C; Arias A; Muñoz C; Rozman M; Villamor N; Colomer D; Montserrat E; Campo E; Carrió A
Br J Haematol; 2012 Mar; 156(5):612-8. PubMed ID: 22150335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]